A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD
Study sponsor: Annovis Bio Inc. · ANVS
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-12-04Actual
Enrollment · participants523Actual
Source updated2025-03-03Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.